FIELD: organic chemistry, medicine, cardiology, pharmacy.
SUBSTANCE: invention relates to a medicinal preparation used in treatment of chronic cardiac insufficiency. The preparation represents 3-methyl-5-[2-(3-tert.-butylamino-2-oxypropoxy)- phenoxymethyl]-1,2,4-oxadoazole hydrochloride. The preparation provides expanding assortment of medicinal agents used in treatment of chronic cardiac insufficiency.
EFFECT: valuable medicinal properties of drug.
5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG EXHIBITING ANTIHYPERTENSIVE, ANTIARRHYTHMIC, CORONARY VESSEL EXPANDING, ANTIISCHEMIC AND ANTIGLAUCOMATOUS ACTIVITY | 1987 |
|
SU1827067A3 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF LEFT VENTRICULAR REMODELING AFTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND HEART FAILURE USING A MULTIVARIATE REGRESSION MODEL | 2022 |
|
RU2806237C1 |
| AGENT FOR TREATMENT OF PATIENT WITH HEART ISCHEMIC DISEASE | 1998 |
|
RU2155036C2 |
| METHOD OF DIFFERENTIAL PRESCRIPTION OF β-ADRENORECEPTOR BLOCKING AGENTS IN PATIENTS WITH CHRONIC CARDIAC FAILURE | 2010 |
|
RU2454998C1 |
| METHOD OF TREATING ACUTE LEFT VENTRICULAR INSUFFICIENCY OF I-III CLASS IN PATIENTS WITH DIABETES MELLITUS | 2009 |
|
RU2423115C2 |
| METHOD OF TREATING PATIENTS WITH OBLITERATING ARTERIAL SCLEROSIS OF LOWER EXTREMITIES COMBINED WITH ISCHEMIC HEART DISEASE | 2013 |
|
RU2525157C1 |
| APPLICATION OF GHRP-6 AS A CARDIOPROTECTIVE AND CARDIORESTORATIVE MEDICINAL PRODUCT FOR LATE TREATMENT | 2019 |
|
RU2779835C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES | 2011 |
|
RU2491070C2 |
| METHOD FOR TREATING PATIENTS WITH CHRONIC HEART FAILURE AT THE BACKGROUND OF ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2213559C2 |
| METHOD OF TREATING PATIENTS WITH ISCHEMIC HEART DISEASE | 2014 |
|
RU2567827C1 |
